Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herbal topical spray for first- and second-degree burn wound healing
IRCT20240309061227N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of silver sulfadiazine in burn injury, first-degree burn and partial-thickness burn (4 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Lesion surface area, Lesion color and 3 more. Started May 2024; status: completed.
02
Drugs
silver sulfadiazine
03
Conditions
burn injuryfirst-degree burnpartial-thickness burn
Beyond the preview
Go deeper on IRCT20240309061227N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240309061227N1.